arginine + rimantadine

**arginine + rimantadine** is a combination of two agents administered orally for the prophylaxis and treatment of influenza A virus infection[5][2]. Rimantadine is a synthetic antiviral drug of the adamantane class that inhibits the replication of influenza A viruses by interfering with the viral M2 ion channel, thereby blocking the uncoating of the virus within infected cells[1][2]. Arginine is an amino acid that has been investigated for its ability to inactivate viruses in acidic solution and may enhance antiviral activity through chemical or immunological mechanisms[3]. This fixed-dose combination is intended to potentiate anti-influenza efficacy or modulate viral resistance.